{"organizations": [], "uuid": "9927ed3593407351bfdbc20a855b86f63898b926", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180425.html", "section_title": "Archive News &amp; Video for Wednesday, 25 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-indoco-remedies-gets-statement-of/brief-indoco-remedies-gets-statement-of-gmp-non-compliance-from-uk-mhra-for-goa-plant-1-idUSFWN1S20LS", "country": "US", "domain_rank": 408, "title": "BRIEF-Indoco Remedies Gets Statement Of GMP Non-Compliance From UK-MHRA For Goa Plant 1", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.044, "site_type": "news", "published": "2018-04-25T19:23:00.000+03:00", "replies_count": 0, "uuid": "9927ed3593407351bfdbc20a855b86f63898b926"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-indoco-remedies-gets-statement-of/brief-indoco-remedies-gets-statement-of-gmp-non-compliance-from-uk-mhra-for-goa-plant-1-idUSFWN1S20LS", "ord_in_thread": 0, "title": "BRIEF-Indoco Remedies Gets Statement Of GMP Non-Compliance From UK-MHRA For Goa Plant 1", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "indoco remedies ltd", "sentiment": "negative"}, {"name": "goa plant", "sentiment": "negative"}, {"name": "on co", "sentiment": "none"}, {"name": "goa", "sentiment": "none"}, {"name": "mhra", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 25 (Reuters) - Indoco Remedies Ltd:\n* GOT STATEMENT OF NON-COMPLIANCE AND RESTRICTED GMP CERTIFICATE FOR GOA PLANT 1 FROM UK-MHRA\n* MHRA STATEMENT SAYS NO EVIDENCE OF PRODUCT HAVING BEEN IMPACTED\n* SAYS IN INTERIM, MEDICALLY CRITICAL PRODUCTS WILL BE ALLOWED TO BE SUPPLIED FROM EFFECTED FACILITY\n* “INSPECTORATE DOES NOT RECOMMEND THAT THE PRODUCTS ARE RECALLED”\n* WILL HAVE TEMPORARY IMPACT ON CO'S BUSINESS TO EUROPE Source text: bit.ly/2HMQJcI Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://bit.ly/2HMQJcI", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-25T19:23:00.000+03:00", "crawled": "2018-04-26T20:15:17.017+03:00", "highlightTitle": ""}